News Articles
For press inquiries, please contact Amy Cook
email: amy@magnusmed.com
phone: 925.222.5094
TV
August 9, 2023
Researchers investigate new revolutionary 5-day therapy for treatment-resistant depression
Researchers investigate new revolutionary 5-day therapy for treatment-resistant depression
Researchers investigate new revolutionary 5-day therapy for treatment-resistant depression
May 16, 2023
Clinical Trial Underway Locally for Potential Breakthrough with Major Depressive Disorder
Clinical Trial Underway Locally for Potential Breakthrough with Major Depressive Disorder
Clinical Trial Underway Locally for Potential Breakthrough with Major Depressive Disorder
RADIO/Podcast
January 5, 2024
A Glimpse of the Future: Electroceuticals for 70%–90% Remission of Depression, Brain Stimulation for Sports Performance, and De-risking Ibogaine for TBI/PTSD (#714)
A Glimpse of the Future: Electroceuticals for 70%–90% Remission of Depression, Brain Stimulation for Sports Performance, and De-risking Ibogaine for TBI/PTSD (#714)
A Glimpse of the Future: Electroceuticals for 70%–90% Remission of Depression, Brain Stimulation for Sports Performance, and De-risking Ibogaine for TBI/PTSD (#714)
October 10, 2022
Dr. Nolan Williams: Psychedelics & Neurostimulation for Brain Rewiring
Dr. Nolan Williams: Psychedelics & Neurostimulation for Brain Rewiring
Dr. Nolan Williams: Psychedelics & Neurostimulation for Brain Rewiring
November 17, 2021
Xtalks Voices: Magnus Medical CEO Dr. Brett Wingeier Talks About Neurostimulation for Depression – Xtalks Life Science Podcast Ep. 37
Xtalks Voices: Magnus Medical CEO Dr. Brett Wingeier Talks About Neurostimulation for Depression – Xtalks Life Science Podcast Ep. 37
Xtalks Voices: Magnus Medical CEO Dr. Brett Wingeier Talks About Neurostimulation for Depression – Xtalks Life Science Podcast Ep. 37
October 30, 2021
A clinical trial of a new brain stimulation technology finds it is very effective in treating severe depression
A clinical trial of a new brain stimulation technology finds it is very effective in treating severe depression
A clinical trial of a new brain stimulation technology finds it is very effective in treating severe depression
August 2, 2024
Magnus Medical tout positive long-term data for neuromodulation system
Magnus Medical tout positive long-term data for neuromodulation system
Magnus Medical tout positive long-term data for neuromodulation system
Following a US launch earlier this year, Magnus’s CEO said the company is expanding access to the therapy.
May 25, 2023
Rapid-Acting Brain Stimulation Method May Reduce Major Depression by Reversing Information Flow Between Brain Regions
Rapid-Acting Brain Stimulation Method May Reduce Major Depression by Reversing Information Flow Between Brain Regions
Rapid-Acting Brain Stimulation Method May Reduce Major Depression by Reversing Information Flow Between Brain Regions
by Peter Tarr, Ph.D., Chief Science Writer, BBRF
December 2022
We Are Witnessing a Revolution in Brain Stimulation
We Are Witnessing a Revolution in Brain Stimulation
We Are Witnessing a Revolution in Brain Stimulation
Information about SAINT may be found on pages 2, 4, 10 and 12.
September 15, 2022
FDA Clears SAINT Rapid-Acting Brain Stimulation Approach for Those Suffering From Resistant Major Depression
FDA Clears SAINT Rapid-Acting Brain Stimulation Approach for Those Suffering From Resistant Major Depression
FDA Clears SAINT Rapid-Acting Brain Stimulation Approach for Those Suffering From Resistant Major Depression
by Peter Tarr, Ph.D., Chief Science Writer, BBRF
September 13, 2022
Magnus receives FDA clearance for neuromodulation system for patients with major depressive disorder
Magnus receives FDA clearance for neuromodulation system for patients with major depressive disorder
Magnus receives FDA clearance for neuromodulation system for patients with major depressive disorder
